bell
The current prices are delayed by 15 mins, login to check live prices.
Jenburkt Pharmaceuticals Ltd share price logo

Jenburkt Pharmaceuticals Ltd

(524731)

₹1129.95.69%

as on 04:01PM, 21 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Jenburkt Pharmaceuticals Ltd Performance

  • Day's Low

    Day's High

    ₹1,063
    ₹1,184
  • 52 Week's Low

    52 Week's High

    ₹643.2
    ₹1,375
1 Month Return+ 15.2 %
3 Month Return+ 15.79 %
1 Year Return+ 75.55 %
Previous Close₹1,198.10
Open₹1,184.00
Volume6,019.00
Upper Circuit-
Lower Circuit-
Market Cap₹528.76Cr

Jenburkt Pharmaceuticals Ltd Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹528.76 Cr
P/B Ratio2.1
EPS0
Dividend Yield0
SectorPharmaceuticals
ROE19.44

Jenburkt Pharmaceuticals Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹528.76 Cr37.89%0.51NANA
NA₹143.16 Cr73.55%0.56NANA
NA₹1,388.42 Cr84.92%0.51₹25 Cr₹212 Cr
NA₹35.53 Cr14.76%0.54NANA
NA₹111.21 Cr51.29%0.55NANA

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd. is a well-established healthcare and pharmaceutical venture, formed by the Bhuta family in 1985. By being listed on the Bombay Stock Exchange, Jenburkt is a public limited company that specializes in manufacturing and marketing high quality pharmaceutical formulations and healthcare products. Headquartered in Mumbai, Jenburkt runs all its operations from the same location.

Founders of the company, the Bhuta family, help maintain the core values of Jenburkt, as over 35 years of experience in the pharmaceutical industry ensures that its products meet the highest standards of quality and efficiency. With a stellar history and experience in the field, Jenburkt continues to serve the healthcare industry with its unique solutions and services.

Share Price: ₹1129.90 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹528.76Cr as of today
Chairperson Name: Ashish U Bhuta
OrganisationJenburkt Pharmaceuticals Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Insights on Jenburkt Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, Jenburkt Pharma stock has moved up by 15.2%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, Jenburkt Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 7.8%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 46.71% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 53.29% of holdings in Sep 2024 quarter

Jenburkt Pharmaceuticals Ltd Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹122.01Cr (-)₹143.80Cr (↑17.86%)₹142.95Cr (↓0.59%)₹166.69Cr (↑16.61%)
Total Liabilities₹23.54Cr (-)₹26.42Cr (↑12.23%)₹20.56Cr (↓22.18%)₹21.75Cr (↑5.79%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹15.02Cr (-)₹19.45Cr (↑29.49%)₹9.27Cr (↓52.34%)₹17.05Cr (↑83.93%)₹8.12Cr (↓52.38%)
0

Jenburkt Pharmaceuticals Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
46.71%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
53.29%
0.00
Others
0%
0.00

Jenburkt Pharmaceuticals Ltd Key Indicators

Details20202021202220232024
Return On Equity %18.8918.4920.6620.5319.44

Jenburkt Pharmaceuticals Ltd Earnings and Dividends

  • Jenburkt Pharmaceuticals Ltd Earnings Results

    Jenburkt Pharmaceuticals Ltd’s net profit jumped 31.15% since last year same period to ₹9.60Cr in the Q2 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 29.38% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Jenburkt Pharmaceuticals Ltd Dividends May,2024

    In the quarter ending March 2024, Jenburkt Pharmaceuticals Ltd has declared dividend of ₹15.30 - translating a dividend yield of 1.35%.

    Read More about Dividends

Jenburkt Pharmaceuticals Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Jenburkt Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.

FAQs on Jenburkt Pharmaceuticals Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Jenburkt Pharmaceuticals Ltd shares.

Jenburkt Pharmaceuticals Ltd (524731) share price today is ₹1129.9

Jenburkt Pharmaceuticals Ltd is not listed on NSE

Jenburkt Pharmaceuticals Ltd is listed on BSE

  • Today’s highest price of Jenburkt Pharmaceuticals Ltd is ₹1184.
  • Today’s lowest price of Jenburkt Pharmaceuticals Ltd is ₹1063.

Today’s traded volume of Jenburkt Pharmaceuticals Ltd(524731) is 6,019.00.

Today’s market capitalisation of Jenburkt Pharmaceuticals Ltd(524731) is ₹528.76Cr.

Jenburkt Pharmaceuticals Ltd(524731Price
52 Week High
₹1375
52 Week Low
₹643.2

Jenburkt Pharmaceuticals Ltd(524731) share price is ₹1129.9. It is down -17.83% from its 52 Week High price of ₹1375

Jenburkt Pharmaceuticals Ltd(524731) share price is ₹1129.9. It is up 75.67% from its 52 Week Low price of ₹643.2

Jenburkt Pharmaceuticals Ltd(524731Returns
1 Day Returns
-68.2%
1 Month Returns
15.2%
3 Month Returns
15.79%
1 Year Returns
75.55%